Hercules Capital, Inc. 6.25% Notes due 2033

Ashland Inc. announced Karl Bostaph's retirement as senior vice president of operations, with Wayne Muil taking over the role effective immediately. Muil brings over 25 years of global operations experience and will oversee Ashland's production facilities worldwide.

Related tickers: HCXY, HTGC, ASH.

MoonLake Immunotherapeutics secures up to $500 million in non-dilutive financing from Hercules Capital, strengthening its financial position to advance its lead candidate sonelokimab. The company plans to provide clinical updates, including on its Phase 3 trials in hidradenitis suppurativa and Phase 2 trial in palmoplantar pustulosis.

Related tickers: MLTX, HCXY, HTGC.